Comparison between Anjali Labtech IPO and Duroflex IPO.
Anjali Labtech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Duroflex IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Anjali Labtech IPO | Duroflex IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | IIFL Capital Services Ltd. | Motilal Oswal Investment Advisors Ltd. JM Financial Ltd. |
| Registrar | Kfin Technologies Ltd. | |
| Market Maker | ||
| DRHP | DRHP  | |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Anjali Labtech IPO is up to ₹0.00 Cr whereas the issue size of the Duroflex IPO is up to ₹0.00 Cr. The final issue price of Anjali Labtech IPO is and of Duroflex IPO is .
| Anjali Labtech IPO | Duroflex IPO | |
|---|---|---|
| Face Value | ₹1 per share | |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹183.60 Cr |
| OFS Issue Size | 0 shares | 2,25,64,569 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Anjali Labtech IPO opens on , while Duroflex IPO opens on . The closing date of Anjali Labtech IPO and Duroflex IPO is , and , respectively.
Anjali Labtech IPO P/E ratio is , as compared to Duroflex IPO P/E ratio of .
| Anjali Labtech IPO | Duroflex IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Anjali Labtech Ltd.'s revenue increased by 110% and profit after tax (PAT) rose by 63% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Duroflex Ltd.'s revenue increased by 4% and profit after tax (PAT) rose by 321% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 14.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anjali Labtech IPO Retail Individual Investors (RII) are offered while in Duroflex IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Anjali Labtech IPO and 0 shares in Duroflex IPO.
| Anjali Labtech IPO | Duroflex IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 0 shares | |
| NII | 0 shares | |
| RII | 0 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares |
Anjali Labtech IPO subscribed in total, whereas Duroflex IPO subscribed .
